Clinical Trials · NCT07083154
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Enrollment
- 420
- Start date
- Sep 2025
- Locations
- 8 sites, China
- Primary endpoint
- Integrated Alzheimer's Disease Rating Scale (iADRS) Score Change